Compositions and methods of targeting cancer stem cells
Described herein are pharmaceutical compositions containing peptoids of general formula (I), (II), or (III) capable of reducing proliferation of cancer stem cells in a subject and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat cancer. Also provided herein are method of detecting and treating cancerous cell masses by use of peptoids of general formula (I), (II), or (III).
1. A pharmaceutical composition comprising a peptoid compound having the general formula (I), an isomer thereof, or a pharmaceutically acceptable derivative thereof:
General formula (I)
and a pharmaceutically acceptable carrier.
2. The pharmaceutical composition of claim 1 , wherein the peptoid compound is present in a therapeutically effective amount in the pharmaceutical composition.
3. A method for reducing proliferation of cancer stem cells in a subject, the method comprising administering to the subject a therapeutically effective amount of a peptoid compound of general formula (I) or a pharmaceutically acceptable derivative thereof:
General formula (I)
4. The method of claim 3 , wherein the cancer stem cells are present as part of a cancerous cell mass.
5. The method of claim 4 , wherein the cancerous cell mass contains cells selected from the group consisting of leukemia, glioblastoma, melanoma, colon cancer, prostate cancer, lung cancer, pancreatic cancer, hepatic cancer, ovarian cancer, and breast cancer.
6. A method for detecting presence of a cancer stem cell in a human tissue sample, the method comprising contacting the human tissue sample with a peptoid having the general formula (I),
General formula (I):
and
detecting binding of said peptoid with a cancer stem cell in said human tissue sample.